✦ LIBER ✦

Chronic Myeloid Leukemia: State of the Art in 2012

✍ Scribed by Carmen Fava, Giovanna Rege-Cambrin, Giuseppe Saglio

Book ID: 115488838
Publisher: Current Science Inc.
Year: 2012
Tongue: English
Weight: 157 KB
Volume: 14
Category: Article
ISSN: 1523-3790
DOI: 10.1007/s11912-012-0253-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

State-of-the-art treatment of chronic ly

State-of-the-art treatment of chronic lymphocytic leukemia

✍ Hallek, M. 📂 Article 📅 2009 🏛 American Society of Hematology 🌐 English ⚖ 126 KB

Treatment of acute myeloid leukemia: Sta

Treatment of acute myeloid leukemia: State-of-the-art and future directions

✍ Richard M Stone 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 102 KB

State of the art in myeloid sarcoma

✍ J. M. KLCO; J. S. WELCH; T. T. NGUYEN; M. Y. HURLEY; F. H. KREISEL; A. HASSAN; A 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 646 KB

Chronic myeloid leukemia in the imatinib

Chronic myeloid leukemia in the imatinib era

✍ Brian J. Druker 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 50 KB

Management of Chronic Myeloid Leukemia i

Management of Chronic Myeloid Leukemia in Childhood

✍ Meinolf Suttorp; Louise Eckardt; Josephine Tabea Tauer; Frederic Millot 📂 Article 📅 2012 🏛 Current Science Inc. 🌐 English ⚖ 203 KB

Management of Chronic Myeloid Leukemia i

Management of Chronic Myeloid Leukemia in Childhood

✍ Meinolf Suttorp; Louise Eckardt; Josephine Tabea Tauer; Frederic Millot 📂 Article 📅 2012 🏛 Current Science Inc. 🌐 English ⚖ 203 KB

Childhood chronic myelogenous leukemia (CML) is a rare malignancy, and experience with optimal treatment is very limited. Traditionally, allogeneic hematopoietic stem cell transplantation was considered the only curative treatment. Imatinib, a small-molecule inhibitor of the BCR-ABL tyrosine kinase